Login
Companies $RMD
$239.10 +$0.91 (0.38%) After hours
RESMED INC logo

RESMED INC

resmed.com

What Do They Do?

Sells sleep and breathing devices, masks and connected health software to home medical equipment providers, hospitals and patients.

How Do They Make Money?

Medical equipment customers pay for sleep and breathing products when they ship. Residential care providers pay for hosted software as services are delivered, with access, support and maintenance also sold for an agreed term.

revenue
SegmentShareRevenue
Sleep and Breathing Health
Sold outright

88%
FY2023: 88%
Residential Care Software
Recurring

12%
FY2023: 12%

Who Are Their Customers?

Home medical equipment providers buy sleep and breathing products and resell them to patients; hospitals and independent distributors also sell the products. Residential care providers generally buy software directly, while some add-on solutions are sold through sales partners.

Do Revenues Turn Into Profits?

Yes. It kept 27 cents of every revenue dollar as net income in FY2026 and turned 29 cents into free cash flow.

Operating income, FY2026
33% of revenue
▲ +12% vs FY2025 ($1.7B, 33%)
Net income, FY2026
27% of revenue
▲ +9% vs FY2025 ($1.4B, 27%)
Free cash flow, FY2026
29% of revenue
▼ −1% vs FY2025 ($1.7B, 32%)

How Are They Changing?

Since the FY2026 annual report
Latest quarter: Q1 FY2027, the three months to Sep 30, 2026
Revenue
▲ +6%
vs $1.3B in Q1 FY2026
Net income
▲ +20%
vs $348.5M in Q1 FY2026
Total Sleep and Breathing Health share of revenue vs 87.6% in Q1 FY2026
  • Aug 17, 2026 ResMed dismissed KPMG and appointed PwC as its auditor The company said there had been no disagreements or reportable events involving KPMG.

Growing. Revenue grew 58% in 4 years, from $3.6B in FY2022 to $5.7B in FY2026, about 12% a year.

Agrees to sell MatrixCare The earlier report described software sold through its MatrixCare subsidiary; the latest report says ResMed has agreed to sell MatrixCare and related software offerings.

Adds restless legs treatment The earlier report described sleep-apnea treatment; the latest report adds an acquired device that treats restless legs syndrome, extending its clinical sleep portfolio.

Expands into home testing services The earlier report described diagnostic products; the latest report adds a software-enabled facility that facilitates in-home and remote testing for sleep, respiratory, cardiac and other conditions.

Revenue over time
Sleep and Breathing Health Residential Care Software
$10B$5B$0

Who Do They Compete With?

Competes with Philips, Fisher & Paykel Healthcare, DeVilbiss Healthcare, Apex Medical, BMC Medical, React Health, Jiangsu Yuyue, and Lowenstein Medical

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support